PDMR share sale
HEADLINE ALTERATION
The headline for the IXICO plc. announcement released on 09/12/2019 at 07:00 am under RNS No 1254W should read PDMR share sale.
The announcement text is unchanged and is reproduced in full below.
09 December 2019
IXICO plc
("IXICO" or the "Company")
PDMR share sale
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 6 December 2019 that on 5 December 2019 John Hall, SVP Corporate Development and a PDMR, sold 100,000 ordinary shares at an aggregated price of 68.00p.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
John James Hall
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
PDMR (SVP Corporate Development) |
|||
|
b)
|
Initial notification /Amendment
|
Initial notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
IXICO plc |
|||
|
b)
|
LEI
|
2138005M1F59O6HWSA97 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares in IXICO plc |
|||
|
|
|
||||
|
Identification code |
GB00BCLY7L40 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Sale |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
68p |
100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
100,000 shares |
||||
|
|
|
||||
|
- Price |
68p |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
5/12/19 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (IXI), UK |
|||
|
IXICO plc |
+44 (0) 20 3763 7498 |
|
Giulio Cerroni, Chief Executive Officer |
|
|
Grant Nash, Chief Financial Officer
|
|
|
Cenkos Securities PLC (Nominated adviser and sole broker) |
+44 (0) 20 7397 8900 |
|
Giles Balleny / Max Gould (Corporate Finance) |
|
|
Michael F Johnson / Russell Kerr (Sales) |
|
|
|
|
|
Optimum Strategic Communications |
+44 (0) 203 950 9144 |
|
Mary Clark / Supriya Mathur / Manel Mateus |
|
|
ixico@optimumcomms.com |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Latest directors dealings
- 41 minutes ago British American Tobacco
- 1 hour ago British American Tobacco
- 1 hour ago HSBC Holdings
- 1 hour ago Bank of Ireland Group (CDI)
- 1 hour ago Prudential